Tetracyclines and Glycylcyclines

Correct Answer

B — Doxycycline

Rationale

Doxycycline is a tetracycline antibiotic. Vancomycin is a glycopeptide. Azithromycin is a macrolide. Ciprofloxacin is a fluoroquinolone. Recognizing doxycycline as the tetracycline among agents from other antibiotic classes is the entire task here.

Correct Answer

D — Second-generation tetracycline

Rationale

Doxycycline is a second-generation tetracycline. The first-generation agent is tetracycline itself. Minocycline is also second-generation. Tigecycline is the glycylcycline — a structurally distinct third-generation subclass. Knowing doxycycline's generational classification within the tetracycline class is the task here.

Correct Answer

A — Second-generation tetracycline

Rationale

Minocycline is a second-generation tetracycline, alongside doxycycline. The first-generation agent is tetracycline itself. Tigecycline is the glycylcycline. Knowing minocycline's generational classification within the tetracycline class is the task here.

Correct Answer

C — Glycylcycline

Rationale

Tigecycline is classified as a glycylcycline — the third-generation tetracycline subclass defined by a structural modification to the minocycline core that distinguishes it from first- and second-generation tetracyclines. Doxycycline and minocycline are second-generation. Tetracycline itself is first-generation. Aminoglycosides are an entirely separate antibiotic class. Knowing tigecycline's class label is the task here.

Correct Answer

B — Tetracycline

Rationale

Tetracycline (the compound sharing its name with the class) is the first-generation agent. Doxycycline and minocycline are second-generation tetracyclines with improved pharmacokinetic properties. Tigecycline is the glycylcycline. Knowing that tetracycline itself is the first-generation agent within the class is the task here.

Correct Answer

A — Tigecycline

Rationale

Tigecycline is the only tetracycline-class antibiotic classified as available exclusively in an intravenous formulation. Doxycycline, minocycline, and tetracycline are all available as oral formulations. Knowing tigecycline's formulation classification within the class is the task here.

Correct Answer

C — Tetracyclines reversibly bind the 30S ribosomal subunit and block the aminoacyl-transfer ribonucleic acid acceptor site, halting protein synthesis in a bacteriostatic manner

Rationale

Tetracyclines bind reversibly to the 30S ribosomal subunit, blocking the acceptor site from receiving incoming aminoacyl-transfer ribonucleic acid. Without aminoacyl-transfer ribonucleic acid delivery, the polypeptide chain cannot be extended and protein synthesis halts. Because this binding is reversible, the drug dissociates when concentrations fall and protein synthesis can resume — making tetracyclines bacteriostatic rather than bactericidal. This distinguishes tetracyclines from aminoglycosides, which also bind the 30S subunit but cause irreversible misreading and are bactericidal. Binding to the 50S subunit and causing misreading are mechanisms of other antibiotic classes.

Correct Answer

A — Doxycycline is eliminated primarily by biliary and intestinal secretion and does not accumulate in renal failure; tetracycline is renally eliminated and accumulates, worsening azotemia through an anti-anabolic effect on protein metabolism

Rationale

The critical pharmacokinetic difference between doxycycline and tetracycline is their elimination route. Tetracycline is predominantly cleared by renal excretion; in renal failure it accumulates, and the elevated drug concentrations produce an anti-anabolic effect — tetracycline interferes with protein anabolism, worsening the nitrogenous waste accumulation (azotemia) that already characterizes renal failure. This makes tetracycline contraindicated in significant renal impairment. Doxycycline bypasses renal clearance as its primary route, relying instead on biliary and intestinal secretion. It does not accumulate in renal failure and requires no dose adjustment. Doxycycline is not efficiently removed by hemodialysis, and its extended half-life reflects its biliary elimination rather than a shorter half-life in renal failure.

Correct Answer

D — Tetracyclines chelate calcium and are incorporated into the calcium-phosphate matrix of developing bone and tooth enamel, causing permanent yellow-brown discoloration and enamel hypoplasia

Rationale

Tetracyclines have high affinity for calcium ions — the same chelating chemistry that enables entry into bacterial cells also binds calcium in human calcified tissues. During periods of active calcification in developing teeth and bone, tetracycline-calcium complexes are irreversibly incorporated into the mineral matrix. In teeth, this produces permanent yellow-brown discoloration and structural enamel hypoplasia. Because the primary dentition begins calcifying in utero and the permanent teeth calcify through approximately age eight, both gestational and childhood exposure carry the same risk of permanent dental effects. The one established exception is doxycycline use in children of any age for Rocky Mountain spotted fever, where the mortality risk of untreated disease outweighs the risk from a single short course. The contraindication is not related to ribosomal toxicity, hepatotoxicity, or hematopoietic effects.

Correct Answer

B — Doxycycline accumulates in skin tissue and is activated by ultraviolet light, generating reactive oxygen species that cause phototoxic tissue damage in sun-exposed areas

Rationale

Doxycycline photosensitivity is a phototoxic reaction, not a photoallergic one. Doxycycline accumulates in skin tissue through its extensive tissue distribution. When skin containing the drug is exposed to ultraviolet light, the drug molecules absorb photonic energy and generate reactive oxygen species that cause direct oxidative damage to skin cells. The resulting reaction resembles an exaggerated, rapidly developing sunburn confined to sun-exposed areas. This is a dose-dependent, non-immunologic reaction that can occur in any patient taking doxycycline — unlike photoallergic reactions, which require prior sensitization and involve IgE or T-cell mechanisms. Patients on doxycycline should apply broad-spectrum sunscreen, wear protective clothing, and limit direct sun exposure. Minocycline has lower photosensitivity risk than doxycycline. The mechanism does not involve melanin synthesis inhibition, vasodilation, or IgE-mediated hypersensitivity.

Correct Answer

A — Minocycline vestibular toxicity is fully reversible on drug discontinuation; aminoglycoside vestibular toxicity can be permanent because hair cells do not regenerate

Rationale

The clinical significance of this distinction lies in the reversibility of the injury. Minocycline causes dose-related vestibular dysfunction — dizziness, vertigo, and ataxia — through a mechanism that does not destroy the vestibular sensory hair cells. Stopping the drug allows symptoms to resolve fully, typically within days to weeks. Aminoglycoside vestibular toxicity, by contrast, causes irreversible destruction of the sensory hair cells in the vestibular apparatus. Mammalian inner ear hair cells do not regenerate, so the resulting disequilibrium and oscillopsia can persist for years or permanently after drug discontinuation. Both are vestibular effects; minocycline does not cause cochlear (hearing) toxicity as a primary adverse effect. Audiometric monitoring is used for cochlear toxicity from aminoglycosides, not for minocycline's vestibular effects.

Correct Answer

C — Pseudomonas aeruginosa has constitutive expression of a multidrug efflux pump that exports tigecycline despite the structural modification that overcomes tetracycline-specific pumps

Rationale

Tigecycline's glycylcycline modification was designed to overcome the two major acquired tetracycline resistance mechanisms: tetracycline-specific efflux pumps and ribosomal protection proteins. This modification is effective against those specific mechanisms. However, Pseudomonas aeruginosa constitutively expresses a broad multidrug efflux pump — a different pump that does not recognize tetracyclines specifically but that efficiently exports a wide range of structurally diverse antibiotics including tigecycline. Because this pump is always expressed regardless of prior antibiotic exposure, tigecycline cannot achieve intracellular concentrations sufficient for ribosomal binding and protein synthesis inhibition in Pseudomonas aeruginosa. The same intrinsic efflux expression accounts for tigecycline's reduced activity against Proteus mirabilis, Providencia stuartii, and Morganella morganii. No glycylcycline-specific inactivating enzyme has been described, and the 30S ribosomal binding site is conserved.

Correct Answer

D — Tigecycline has a very large volume of distribution that concentrates drug in tissues; the resulting relatively low plasma concentrations are inadequate to achieve the minimum inhibitory concentration in the bloodstream

Rationale

Tigecycline's volume of distribution far exceeds total body water, reflecting extensive binding to tissues throughout the body. While this produces high intracellular concentrations in tissues — useful for treating infections in organs such as the skin, abdomen, and lung — it means that plasma drug concentrations after standard intravenous dosing are relatively low. In bacteremia, the infecting organisms are in the bloodstream where tigecycline concentrations are insufficient to consistently achieve the minimum inhibitory concentration for killing. This pharmacokinetic mismatch explains the inadequacy for bacteremia. An FDA safety communication noted higher all-cause mortality in tigecycline-treated patients across several indications, with the strongest signal in patients with bacteremia. Rapid hepatic metabolism does not occur with tigecycline at standard doses, and while protein binding is high, the dominant pharmacokinetic factor driving low plasma concentrations is the extensive tissue redistribution.

Correct Answer

B — Tetracyclines halt bacterial growth and protein synthesis; bactericidal cell-wall-active agents require actively growing and dividing bacteria to exert their lethal effects, so the combination produces antagonism

Rationale

Beta-lactams and other cell-wall-active bactericidal agents kill bacteria by blocking peptidoglycan cross-linking during active cell wall synthesis — a process that only occurs when bacteria are actively growing and dividing. Tetracyclines halt bacterial protein synthesis, which secondarily arrests bacterial growth. When bacteria are in a static, non-growing state, cell wall turnover ceases and there is no active synthesis for beta-lactams to target. The result is pharmacodynamic antagonism: the tetracycline's bacteriostatic effect protects the organism from the bactericidal cell-wall agent by freezing bacteria in a state where the bactericidal mechanism cannot operate. This antagonism is clinically important in infections where bactericidal activity is required for cure — bacterial meningitis and endocarditis — and explains why tetracyclines are avoided in these contexts. The interaction is pharmacodynamic, not pharmacokinetic; no chelation of cofactors or enzyme induction is involved.

Correct Answer

D — Doxycycline accumulates in phagocytic cells and infected host cells, where it reversibly binds the 30S ribosomal subunit of Rickettsia rickettsii and halts its protein synthesis

Rationale

Rickettsia rickettsii is an obligate intracellular pathogen that resides and replicates within the cytoplasm of endothelial cells. Antibiotics must concentrate intracellularly to reach the organism. Tetracyclines achieve this because of their lipophilicity and active uptake into host cells, reaching concentrations inside infected cells that exceed plasma levels. Once inside, doxycycline binds reversibly to the 30S ribosomal subunit of Rickettsia, blocking aminoacyl-transfer ribonucleic acid entry and halting protein synthesis — the standard tetracycline bacteriostatic mechanism applied in the intracellular environment. Doxycycline is the drug of choice for Rocky Mountain spotted fever, including in children of any age where the mortality risk of untreated disease outweighs the risk of a single short course of doxycycline. Rickettsia lacks a cell wall that would be susceptible to beta-lactams, and the mechanism is ribosomal inhibition, not gyrase inhibition.

Correct Answer

B — Doxycycline is eliminated by biliary and intestinal secretion and does not accumulate in renal failure; tetracycline is renally eliminated, accumulates in renal failure, and worsens azotemia through an anti-anabolic effect on protein metabolism

Rationale

The selection of doxycycline over tetracycline in this patient is driven entirely by pharmacokinetics, not by spectrum differences. Both agents are active against Chlamydia trachomatis. The critical difference is elimination: tetracycline depends on renal excretion and accumulates in renal impairment, causing elevated drug concentrations that interfere with protein anabolism and worsen azotemia — an anti-anabolic effect that directly harms patients with already-reduced kidney function. Doxycycline's primary elimination route is biliary and intestinal secretion, bypassing the kidneys. It does not accumulate in renal failure and requires no dose adjustment, making it the appropriate choice in this patient. Photosensitivity risk does not differ based on renal function, and differences in intracellular penetration or speed of killing are not the basis for this selection.

Correct Answer

A — Tetracyclines chelated calcium ions and were incorporated into the calcium-phosphate matrix of developing tooth enamel during active calcification, producing permanent yellow-brown discoloration and enamel hypoplasia

Rationale

Tetracyclines have a strong affinity for calcium ions. When drug circulating in the blood encounters the calcium-phosphate hydroxyapatite matrix of bone and developing tooth enamel during active calcification, tetracycline-calcium complexes form and are irreversibly incorporated into the mineral structure. The deposits produce yellow-brown discoloration that darkens further with ultraviolet light exposure over time, and the structural disruption of enamel formation produces hypoplasia — defects in enamel thickness and surface integrity. Because permanent tooth calcification occurs from approximately age three to age eight, this patient's exposure between ages four and seven placed him in the high-risk window. The finding is permanent because once enamel is formed and the ameloblasts cease activity, no remodeling occurs. This is why tetracyclines (and doxycycline) are contraindicated in children under eight except for the specific indication of Rocky Mountain spotted fever, where mortality risk takes precedence.

Correct Answer

C — Tigecycline's very large volume of distribution concentrates drug in tissues and produces low plasma concentrations that are insufficient to achieve bactericidal levels in the bloodstream, despite adequate tissue penetration

Rationale

In vitro susceptibility testing is performed with controlled drug concentrations that may not reflect the concentrations achievable in the bloodstream during tigecycline therapy. Tigecycline distributes extensively into tissues, resulting in plasma drug concentrations after standard intravenous dosing that are relatively low — often below the minimum inhibitory concentration for the infecting organism when that organism is present in high density in the blood. This pharmacokinetic mismatch between tissue concentrations (adequate) and plasma concentrations (insufficient) explains why tigecycline monotherapy fails for bacteremia even when the organism appears susceptible in vitro. An FDA safety analysis confirmed higher mortality with tigecycline across multiple indications, with the signal concentrated in bacteremic patients. Carbapenem-resistant Klebsiella pneumoniae does not have constitutive efflux that specifically overcomes glycylcycline modification — that is the mechanism in Pseudomonas aeruginosa. Tigecycline does not undergo rapid hepatic inactivation at standard doses.